NasdaqGS:XRAY

Stock Analysis Report

Executive Summary

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.


Snowflake Analysis

Excellent balance sheet and slightly overvalued.


Similar Companies

Share Price & News

How has DENTSPLY SIRONA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: XRAY's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.1%

XRAY

3.7%

US Medical Equipment

2.4%

US Market


1 Year Return

-24.7%

XRAY

-1.6%

US Medical Equipment

-10.0%

US Market

Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned -5.2% over the past year.

Return vs Market: XRAY underperformed the US Market which returned -13.3% over the past year.


Shareholder returns

XRAYIndustryMarket
7 Day2.1%3.7%2.4%
30 Day-9.6%-5.6%-11.0%
90 Day-33.8%-14.5%-19.4%
1 Year-24.1%-24.7%-0.8%-1.6%-8.1%-10.0%
3 Year-37.2%-38.6%50.7%46.6%17.3%9.6%
5 Year-22.9%-25.4%81.9%63.2%36.1%21.1%

Price Volatility Vs. Market

How volatile is DENTSPLY SIRONA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is DENTSPLY SIRONA undervalued compared to its fair value and its price relative to the market?

32.32x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: XRAY ($38.09) is trading above our estimate of fair value ($34.41)

Significantly Below Fair Value: XRAY is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: XRAY is good value based on its PE Ratio (32.3x) compared to the Medical Equipment industry average (37.5x).

PE vs Market: XRAY is poor value based on its PE Ratio (32.3x) compared to the US market (12.5x).


Price to Earnings Growth Ratio

PEG Ratio: XRAY is poor value based on its PEG Ratio (1.8x)


Price to Book Ratio

PB vs Industry: XRAY is good value based on its PB Ratio (1.7x) compared to the US Medical Equipment industry average (2.9x).


Next Steps

Future Growth

How is DENTSPLY SIRONA forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?

18.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: XRAY's forecast earnings growth (18.4% per year) is above the savings rate (1.7%).

Earnings vs Market: XRAY's earnings (18.4% per year) are forecast to grow faster than the US market (13.4% per year).

High Growth Earnings: XRAY's earnings are forecast to grow, but not significantly.

Revenue vs Market: XRAY's revenue (2.3% per year) is forecast to grow slower than the US market (7% per year).

High Growth Revenue: XRAY's revenue (2.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (11%).


Next Steps

Past Performance

How has DENTSPLY SIRONA performed over the past 5 years?

-38.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: XRAY has a large one-off loss of $196.9M impacting its December 31 2019 financial results.

Growing Profit Margin: XRAY became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: XRAY has become profitable over the past 5 years, growing earnings by -38.5% per year.

Accelerating Growth: XRAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: XRAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1%).


Return on Equity

High ROE: XRAY's Return on Equity (5.2%) is considered low.


Next Steps

Financial Health

How is DENTSPLY SIRONA's financial position?


Financial Position Analysis

Short Term Liabilities: XRAY's short term assets ($2.0B) exceed its short term liabilities ($995.5M).

Long Term Liabilities: XRAY's short term assets ($2.0B) do not cover its long term liabilities ($2.5B).


Debt to Equity History and Analysis

Debt Level: XRAY's debt to equity ratio (28.4%) is considered satisfactory.

Reducing Debt: XRAY's debt to equity ratio has reduced from 54.5% to 28.4% over the past 5 years.

Debt Coverage: XRAY's debt is well covered by operating cash flow (43.8%).

Interest Coverage: XRAY's interest payments on its debt are well covered by EBIT (19.5x coverage).


Balance Sheet


Next Steps

Dividend

What is DENTSPLY SIRONA's current dividend yield, its reliability and sustainability?

1.05%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: XRAY's dividend (1.05%) isn’t notable compared to the bottom 25% of dividend payers in the US market (2.01%).

High Dividend: XRAY's dividend (1.05%) is low compared to the top 25% of dividend payers in the US market (5.66%).


Stability and Growth of Payments

Stable Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: XRAY is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of XRAY's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Don Casey (59yo)

2.17s

Tenure

US$11,338,542

Compensation

Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since  ...


CEO Compensation Analysis

Compensation vs Market: Don's total compensation ($USD11.34M) is above average for companies of similar size in the US market ($USD7.61M).

Compensation vs Earnings: Insufficient data to compare Don's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Donald Casey
CEO & Director2.17yrsUS$11.34m0.037% $3.1m
Keith Ebling
EVP, General Counsel & Secretary2.5yrsUS$2.33m0.0025% $209.2k
William Newell
Senior Vice President of Chairside Consumables2.75yrsUS$1.48m0.0087% $734.7k
Markus Boehringer
Senior Vice President of EMEA RCO2.75yrsUS$1.52m0.011% $961.5k
Jorge Gomez
Executive VP & CFO0.67yrno datano data
Cord Staehler
Chief Technology Officer0.92yrno datano data
John Sweeney
Vice President of Investor Relationsno datano datano data
Lisa Yankie
Senior VP and Chief HR Officer & Communications0.50yrno datano data
Albert Sterkenburg
Senior Vice President11.25yrsUS$1.35mno data
Teresa Dolan
Chief Clinical Officer & VPno datano datano data

2.3yrs

Average Tenure

55yo

Average Age

Experienced Management: XRAY's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Donald Casey
CEO & Director2.17yrsUS$11.34m0.037% $3.1m
Francis Lunger
Independent Director14.92yrsUS$282.50k0.0092% $776.8k
Eric Brandt
Non-Executive Chairman2.58yrsUS$398.88k0.010% $846.8k
Harry M. Kraemer
Independent Director4.17yrsUS$270.00k0.055% $4.6m
Betsy Holden
Independent Director2.25yrsUS$261.75k0.0012% $103.7k
Michael Alfano
Independent Director19.17yrsUS$270.00k0.0046% $385.5k
Leslie Varon
Independent Director2.25yrsUS$264.16kno data
Gregory Lucier
Independent Director0.92yrno data0.0045% $381.2k
Arthur Kowaloff
Independent Director4.17yrsUS$272.50k0.017% $1.4m
William Deese
Independent Director9.17yrsUS$272.50k0.0054% $453.8k

3.4yrs

Average Tenure

63.5yo

Average Age

Experienced Board: XRAY's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DENTSPLY SIRONA Inc.
  • Ticker: XRAY
  • Exchange: NasdaqGS
  • Founded: 1899
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$8.435b
  • Shares outstanding: 221.44m
  • Website: https://www.dentsplysirona.com

Number of Employees


Location

  • DENTSPLY SIRONA Inc.
  • 13320 Ballantyne Corporate Place
  • Charlotte
  • North Carolina
  • 28277
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
XRAYNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDAug 1987
DY2DB (Deutsche Boerse AG)YesCommon StockDEEURAug 1987
0I8FLSE (London Stock Exchange)YesCommon StockGBUSDAug 1987
XRAYWBAG (Wiener Boerse AG)YesCommon StockATEURAug 1987
DY2ETLX (Eurotlx)YesCommon StockITEURAug 1987
XRAY34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH REP 1 COM USD0.01BRBRLMay 2019

Biography

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/08 02:51
End of Day Share Price2020/04/07 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.